June 30,
2022

December 31,
2021

Accrued clinical operations and trials costs

$

1,263,216

$

5,435,464

Accrued product development costs

5,800

203,676

Accrued compensation

1,720,608

2,715,368

Accrued administrative costs

1,056,074

1,213,699

Accrued interest

670,724

525,105

Total

$

4,716,422

$

10,093,312